Veness Adam M

SVP, General Counsel and Sec.Dianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Aug 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.2M
Net Open-Market Flow
-$2.2M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2026Option exercise(M)16K$17.88$289K16K
Aug 10, 2026Sell(S)16K$110.38$1.8M0
Aug 7, 2026Sell(S)616$111.18$68K0
Aug 7, 2026Option exercise(M)4K$17.88$69K4K
Aug 7, 2026Sell(S)3K$110.61$356K616

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 10, 2026Option exercise(M)16K$060K
Aug 7, 2026Option exercise(M)4K$076K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001778623-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.